GGrantIndex
Sort

39,280 grants matching leukemia

Project 4: Novel epigenetic treatment of IDH mutant gliomas

$337,783
Harley I Kornblum · University Of California Los Angeles · P50 · FY2021 · CA

Chelation strategies for s-, p-, and f-block radionuclides for targeted alpha therapy

$337,767
Justin J Wilson · Cornell University · R01 · FY2023 · EB

Project 2: Alpha-Emitter Radioimmunotherapy-Based Allografting to Cure Acute Leukemia and Myelodysplastic Syndrome

$337,761
Brenda Marie Sandmaier · Fred Hutchinson Cancer Center · P01 · FY2022 · CA

Mechanisms of Leukemogenesis in Down Syndrome

$337,725
John D Crispino · Northwestern University At Chicago · R01 · FY2018 · CA

Origin of CD5+ B cell Lymphoma/Leukemia in Mice

$337,720
Kyoko Hayakawa · Research Inst Of Fox Chase Can Ctr · R01 · FY2013 · CA

Development Of P2Y Receptor Ligands

$337,718
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK

Pathology

$337,691
Sherif S Farag · Ohio State University · P01 · FY2010 · CA

Shwachman-Diamond Syndrome: Molecular Pathogenesis

$337,666
Children'S Hospital Boston · R01 · FY2005 · HL

Function and Biology of Eukaryotic DNA Topoisomerases

$337,664
Neil Osheroff · Vanderbilt University · R01 · FY2006 · GM

Lymphoma Studies

$337,660
Wyndham H Wilson · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA

Project 1: Immune Regulation in HCT

$337,646
Robert S Negrin · Stanford University · P01 · FY2022 · CA

SOUTHWEST ONCOLOGY GROUP

$337,644
University Of Rochester · U10 · FY2002 · CA

Mechanisms of apoptotic calcium signaling

$337,615
Darren F Boehning · University Of Texas Hlth Sci Ctr Houston · R01 · FY2015 · GM

Cancer Stem Cells in Acute Lymphoblastic Leukemia and Ovarian Carcinoma

$337,575
Richard J Jones · Johns Hopkins University · P01 · FY2008 · CA

Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients

$337,529
Victor H. Engelhard · University Of Virginia · R01 · FY2018 · CA

Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients

$337,529
Victor H. Engelhard · University Of Virginia · R01 · FY2017 · CA

Project 3 - Novel Therapies for Spliceosomal-Mutant MDS.

$337,504
Matthew J Walter · Washington University · P50 · FY2018 · CA

Genetic Analysis of H2B Ubiquitylation in Yeast

$337,500
Mary Ann Osley · University Of New Mexico · R01 · FY2008 · GM

Modulating the tumor micro-environment in CLL using flavopiridol and lenalidomide

$337,500
Kristie A Blum · Ohio State University · R21 · FY2009 · CA

FANCD2 Monoubiquitination in DNA Damage Responses

$337,500
Paul R Andreassen · Cincinnati Childrens Hosp Med Ctr · R01 · FY2011 · HL

LIGHT co-stimulatory therapy on GVHD and GVL

$337,500
Scott E. Strome · University Of Maryland Baltimore · R01 · FY2011 · HL

BENZENE METABOLITES AND HEMATOTOXICITY

$337,500
University Of Texas Austin · R01 · FY2002 · ES

Genetic Analysis of H2B Ubiquitylation in Yeast

$337,500
Mary Ann Osley · University Of New Mexico · R01 · FY2007 · GM

FANCD2 Monoubiquitination in DNA Damage Responses

$337,500
Paul R Andreassen · Cincinnati Childrens Hosp Med Ctr · R01 · FY2009 · HL

Genetic Analysis of H2B Ubiquitylation in Yeast

$337,500
Mary Ann Osley · University Of New Mexico · R01 · FY2009 · GM